A spectrophotometric flow injection method for the determination of Zn(II) in ophthalmic formulations was developed. In this work, Zn(II) ion was complexed with Alizarin red S in borate buffer solution (pH 9.0) and the chromophore produced was monitored at 520 nm. The analytical curve was linear in the Zn(II) concentration range from 6.05 x 10 -6 to 1.50 x 10 -4 mol L -1 with a detection limit of 3.60 x 10 -6 mol L -1 . Recoveries ranged from 96.3 to 105 % and a relative standard deviation of 1.2 % (n = 10) for 5.5x10
Introduction
Zinc compounds have bactericidal activity since they can precipitate and denature several bacterial proteins. For this reason, they have been employed as antiseptic and disinfectant agents in pharmaceutical products such as creams, ointments and eye drops [1, 2] . The antibacterial activity is enhanced in the mixture with quaternary ammonium compounds. Thus, the determination of Zn(II) in pharmaceutical preparations is an important analytical task.
The USP XXIII Pharmacopoeia recommends the determination of Zn(II) by atomic absorption spectrometry (AAS) or by an extractive spectrophotometric method [3] .
Several spectrophotometric procedures reported in the literature for the determination of Zn(II) are summarized by Bhalotra et al. [4] and a previous solvent extraction step is required in other spectrophotometric methods [5] [6] [7] [8] [9] . Electroanalytical methods such as potentiometry [10] [11] [12] , potenciometric stripping analysis [13, 14] and anodic redissolution stripping voltammetry also were described [15] .
Several flow injection methods have been proposed employing different detections such as optosensor [16] [17] [18] [19] , anodic stripping voltammetry [20] , diode array [21] and electrothermal atomic absorption spectrometry [22] . A multicommutation flow procedure [23] and a sequential injection analysis system [20] were described for the determination of Zn(II) in pharmaceutical formulations
The development of automated flow procedures are of the great interest to quality control laboratories due the high number of analysis and possibility of data acquisition.
In this work we present a simple flow injection method for determining Zn(II) in pharmaceutical solutions based on the formation of a water soluble complex between Alizarin red S (ALZ) and Zn 2+ [24] .
Experimental

Apparatus
A model 8452A Hewlett-Packard (Boise, ID, USA) UV-visible spectrophotometer was used in a comparative spectrophotometric method for Zn 2+ in the ophthalmic formulations samples [8] .
A peristaltic pump supplied with Tygon ® pump tubing was used for the propulsion of the solutions. The manifold was constructed with polyethylene tubing (0.8 mm i.d.). The solutions were injected using an injector-commutator 2-3-2 made of Perspex ® [25] . The detection was performed using a spectrophotometer (Femto, Model 435, São Paulo) equipped with a glass flow-cell (optical path, 10 mm). The absorbance was recorded using a two-channel strip-charter recorder Model 1202-0000 Cole Parmer (Chicago, IL, USA) connected to spectrophotometer.
Reagents and solutions
All reagents used were of analytical grade and water from a Millipore (USA) Milli-Q system was used throughout. Zinc sulphate heptahydrate and Borax were obtained from Mallinckrodt. Red Alizarin red S was purchase from Vetec ® (São Paulo, Brazil -4 mol L -1 Alizarin Red S working solution was prepared by diluting 3.0 mL in the 100.0 mL calibrated flask and the volume was completed with the same 1.6x10 -2 mol L -1 buffer solution (pH 9.0).
Flow injection system
A schematic diagram of the flow manifold in injection position is shown in Figure 1 
Preparation of pharmaceutical samples
Three Brazilian pharmaceutical formulations containing Zn(II) such as Moura Brasil ® (Aventis Pharma LTDA.), Lerin ® (Allergan Produtos Farmacêuticos LTDA) and Zincolok ® (Allergan Produtos Farmacêuticos Ltda) were analyzed using a proposed flow injection procedure. Eye drops formulations were appropriately diluted with desionized water to obtain a concentration of ca. 5.0 x 10 -5 mol L -1 of Zn(II) in the diluted solution of samples. The results obtained by the proposed flow injection method were compared with the results obtained by a spectrophotometric batch procedure described by Manouri et al. [8] .
Results and discussion
The proposed flow injection procedure for the determination of Zn 2+ was based on the formation of complex with Alizarin red S in borate buffer (pH 9.0).
The optimization of chemical and flow injection parameters were performed using a univariate method in order to achieve a best compromise between the peak height, sample throughput, reproducibility and baseline stability.
Chemical parameters
To establish the best conditions for the Zn(II) determination, some chemical parameters such as carrier solution and Alizarin Red S concentration were investigated. The optimized values studied and selected were showed in the Table 1 . Carrier flow rate / mL min Initially, the effect of the carrier solution on the analytical signal was studied using 0.01 mol L -1 buffer solutions (acetate and borate buffers) in the pH range from 7.1 to 9.8. The buffer solution that promoted the highest analytical signals was 0.01 mol L -1 borate buffer at pH 9.0. Thus, the 1.6x10 -2 mol L -1 borate buffer at pH 9.0 was selected for further experiments.
The effect of Alizarin red S solution on the analytical signal was studied between 7.5x10 
Flow injection parameters
To determine the optimum flow procedure parameters, the sample volume, carrier and reagent flow rate and reactor coil length were investigated. The parameters range studied and selected are shown in Table 1 . The effect of sample volume from 100 to 350 µL (50 to 70 cm) on the analytical signal was evaluated by injection of 6.0 x 10 -4 mol L -1 Zn 2+ solution in 0.01 mol L -1 borate buffer (pH 9.0). The analytical signal increased with the increasing of sample volumes up to 250 µL above which it remained constant. Thus, the volume of 250 µL was selected as optimum.
The effect of the Alizarin red S flow rate and the carrier flow rate on the analytical signal were studied from 0.7 to 1.7 mL min -1 each one. The flow rates of 1.2 mL min -1 were selected to each channels because promotes the higher analytical signals.
The influence of tubular coiled reactor length on the absorbance was also evaluated in the range from 50 to 230 cm using a 4.0x10 -5 mol L -1 Zn 2+ reference solution. The analytical signal increased gradually with increase of length up to 230 cm. To the highest reactor lengths, the baseline was achieved slowly due the impregnation of complex on the glass flow cell. This impregnation was not observed up to 150 cm reactor length. Thus, the 150 cm reactor coil length was chosen, taking account height of the analytical signal and analytical frequency.
Recoveries and interferences studies
The recovery study was examined by adding Zn 2+ reference solution at three levels ( from three pharmaceutical formulations were obtained using the optimized flow procedure. The results are shown in the Table 2 and suggests no significant matrix effect in the samples studied. The interference of some compounds commonly founded in eye drop formulations was studied with the proposed flow procedure. Chloride sodium, benzalkonium chloride, citric acid, CuSO 4 and EDTA were tested. In this study, aliquots of solutions containing the interferences at three concentration levels were added to 5.0x10 -5 mol L -1 Zn 2+ reference solution. The results obtained in Zn 2+ determination in theses solutions were compared with those obtained of the reference solutions without interference added. The tolerated concentration was that promote the signal variation of ±5 %. In these group of substances studied, only the benzalkonium chloride causes severe interference on the response of proposed procedure at same concentration that Zn(II) standard solution. The cationic surfactant, such as benzalkonium chloride promotes a hyperchromic shift of the complex spectrum [27] . This benzalkonium chloride concentration was not founded in the analyzed commercial formulations. To others substances, no interference was observed in the response of flow system procedure in the presence of 10-fold excess of these studied substances. Cu 2+ causes severe interference due the formation of stable complex with Alizarin red S with considerable overlapping of the spectra of their of Zn(II)-Alizarin complex [24] . The use of thiosulphate and thiourea as the masking reagent for Cu 
Analytical curve and applications
In the optimized conditions, the analytical curve was linear in the concentration range from 6.0x10 Table 3 . The results obtained using the proposed flow procedure are in good agreement with the results obtained by batch procedure [8] at 95% confidence level (t-paired test) [28] . Table 3 . Determination of Zn 2+ in commercial formulations by using flow procedure and comparative batch procedure [29] Samples Zn 2+ (mg mL n=3, mean ± standard deviation; Re 1 , relative error between proposed flow procedure vs. comparative method. Sample composition: zinc sulphate or zinc phenolsulphonate, sodium borate, acid boric, potassium chloride, citric acid, disodium edetate dehydrated, Thimerosa
Conclusions
The flow injection procedure proposed was applied to the determination of Zn 2+ contained in eye drop solutions. The automatized procedure is simple, precise and has sensitive enough for the analysis of a variety of ophthalmic solutions with high sample throughput. Thus, the developed flow injection procedure is very suitable for routine analytical applications. 2+ em colírios empregando-se o procedimento proposto estão em concordância com os resultados obtidos empregando-se um procedimento comparativo a um nível de confiança de 95%.
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